NEW YORK (GenomeWeb News) – Belgian spectrophotometer firm Trinean today said it has licensed intellectual property covering microfluidic technologies from PerkinElmer's Caliper Life Sciences business directed at UV-VIS quantification analysis.
The license allows Trinean to design and develop microfluidic cartridges and instruments for the UV/VIS quantification of light-absorbing substances for certain life science applications, Trinean said. Further details of the deal were not disclosed.
"The combined IP from Trinean and PerkinElmer will boost the expansion of our platform for DNA, RNA, and protein quantification and quality control," Philippe Stas, CEO of Trinean, said in a statement.
"The use of microfluidics for UV/Vis spectrometry is an exciting market development,"
Kevin Hrusovsky, life sciences president for PerkinElmer, added. "We continue to leverage our microfluidics portfolio through licensing collaborations such as our agreement with Trinean to extend our market reach and create additional revenue opportunities."
Caliper and Trinean inked a deal two years ago giving Caliper exclusive rights to distribute the Belgian company's automated UV/Vis spectral analysis platform in North America.